Synthesis of Non-Symmetrical Nitrogen-Containing Curcuminoids in the Pursuit of New Anticancer Candidates.

anticancer activity antioxidant activity curcumin cytotoxicity water solubility

Journal

ChemistryOpen
ISSN: 2191-1363
Titre abrégé: ChemistryOpen
Pays: Germany
ID NLM: 101594811

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 13 12 2018
revised: 05 02 2019
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 9 3 2019
Statut: epublish

Résumé

Curcumin is known to display pronounced anticancer effects and a variety of other biological activities. However, the low bioavailability and fast metabolism of this molecule present an issue of concern with respect to its medicinal applications. To address this issue, structural modifications of the curcumin scaffold can be envisioned as a strategy to improve both the solubility and stability of this chemical entity, without compromising its biological activities. Previous work in our group targeted the synthesis of symmetrical azaheteroaromatic curcuminoids, which showed better solubility and cytotoxicity profiles compared to curcumin. In continuation of that work, we now focused on the synthesis of non-symmetrical nitrogen-containing curcuminoids bearing both a phenolic and an azaheteroaromatic moiety. In that way, we aimed to combine good solubility, antioxidant potential and cytotoxic properties into one molecule. Some derivatives were selected for further chemical modification of their rather labile β-diketone scaffold to the corresponding pyrazole moiety. In this way, thirteen new non-symmetrical aza-aromatic curcuminoids and four pyrazole-based analogues were successfully synthesized in a yield of 11-69 %. All newly synthesized analogues were evaluated for their antioxidant properties, reactive oxygen species (ROS) production, water solubility and anticancer activities. Several novel derivatives displayed good cytotoxicity profiles compared to curcumin, in combination with an improved water solubility and stability, and were thus identified as potential hit scaffolds for further optimization studies.

Identifiants

pubmed: 30847262
doi: 10.1002/open.201800287
pii: OPEN201800287
pmc: PMC6392825
doi:

Types de publication

Journal Article

Langues

eng

Pagination

236-247

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5765-9
pubmed: 21885280
DNA Repair (Amst). 2006 Feb 3;5(2):145-52
pubmed: 15878696
J Pharm Pharmacol. 1994 Dec;46(12):1013-6
pubmed: 7714712
Cell Biophys. 1989 Apr;14(2):175-85
pubmed: 2472207
Cancer Biol Ther. 2010 Jan;9(2):109-10
pubmed: 19949311
Antioxid Redox Signal. 2008 Mar;10(3):511-45
pubmed: 18370854
Biochem Biophys Res Commun. 2005 Jan 14;326(2):472-4
pubmed: 15582601
Clin Cancer Res. 2001 Jul;7(7):1894-900
pubmed: 11448902
Biochim Biophys Acta. 1996 Nov 15;1317(2):95-100
pubmed: 8950193
Anal Sci. 2001 Jul;17(7):893-5
pubmed: 11708126
J Org Chem. 2004 Sep 3;69(18):5888-96
pubmed: 15373474
J Med Chem. 1991 Feb;34(2):518-25
pubmed: 1847426
Free Radic Biol Med. 2010 Mar 15;48(6):749-62
pubmed: 20045723
Biol Pharm Bull. 2007 Jan;30(1):74-8
pubmed: 17202663
J Carcinog. 2006 May 11;5:14
pubmed: 16689993
Mol Cell Biochem. 1992 Apr;111(1-2):117-24
pubmed: 1588934
Ann N Y Acad Sci. 2002 Apr;959:199-213
pubmed: 11976197
Drug Metab Dispos. 1999 Apr;27(4):486-94
pubmed: 10101144
Anal Biochem. 1996 Jul 15;239(1):70-6
pubmed: 8660627
Planta Med. 1998 May;64(4):353-6
pubmed: 9619120
Xenobiotica. 1994 Mar;24(3):265-79
pubmed: 8009889
Biomed Res Int. 2013;2013:239354
pubmed: 24089667
J Pharm Biomed Anal. 1997 Aug;15(12):1867-76
pubmed: 9278892
J Phys Chem B. 2017 May 25;121(20):5300-5307
pubmed: 28471675
ChemistryOpen. 2018 May 25;7(5):381-392
pubmed: 29872613
Brain Behav. 2014 Mar;4(2):108-22
pubmed: 24683506
J Med Chem. 2017 Mar 9;60(5):1620-1637
pubmed: 28074653
Chem Biol Interact. 2008 Jul 10;174(1):27-37
pubmed: 18547552
Antimicrob Agents Chemother. 2007 Feb;51(2):488-94
pubmed: 17145789
Bioorg Med Chem. 2009 Jan 1;17(1):360-7
pubmed: 19019687
Bioorg Med Chem. 2011 Nov 1;19(21):6196-202
pubmed: 21975067
Bioorg Med Chem. 2015 Nov 15;23(22):7165-80
pubmed: 26515041
AAPS J. 2013 Jan;15(1):195-218
pubmed: 23143785
Drug Metab Dispos. 2007 May;35(5):699-703
pubmed: 17287390
Bioorg Med Chem. 2002 Nov;10(11):3481-7
pubmed: 12213462
Cancer Lett. 1985 Nov;29(2):197-202
pubmed: 4075289
Chem Biol Drug Des. 2018 Jan;91(1):338-343
pubmed: 28741789
Cancer Res. 1999 Jul 15;59(14):3387-91
pubmed: 10416599
Adv Exp Med Biol. 2007;595:105-25
pubmed: 17569207
Bioorg Med Chem Lett. 2017 Sep 1;27(17):3974-3979
pubmed: 28797799
Biochemistry. 2013 Oct 22;52(42):7449-60
pubmed: 24063255
Nutr Cancer. 2010;62(7):919-30
pubmed: 20924967
Drug Resist Updat. 2004 Apr;7(2):97-110
pubmed: 15158766
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7
pubmed: 18559556
Cancer Lett. 1995 Jul 20;94(1):79-83
pubmed: 7621448
Mol Pharm. 2007 Nov-Dec;4(6):807-18
pubmed: 17999464
Eur J Med Chem. 2016 Jun 30;116:102-115
pubmed: 27060762
J Ethnopharmacol. 1993 Mar;38(2-3):113-9
pubmed: 8510458
Carcinogenesis. 1998 Jun;19(6):1039-43
pubmed: 9667742
Antimicrob Agents Chemother. 2006 May;50(5):1859-60
pubmed: 16641461
Bioorg Med Chem. 2008 Mar 15;16(6):2894-902
pubmed: 18194869
Biochim Biophys Acta. 2008 Apr;1780(4):673-9
pubmed: 18178166
Bioorg Med Chem. 2002 Sep;10(9):2987-92
pubmed: 12110321
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Biochem J. 2013 Sep 1;454(2):201-8
pubmed: 23772801
Langmuir. 2009 May 19;25(10):5773-7
pubmed: 19320475
Pharmacogenet Genomics. 2011 Jul;21(7):440-6
pubmed: 21048526
Physiol Rev. 2011 Jan;91(1):151-75
pubmed: 21248165
ChemistryOpen. 2019 Feb 27;8(2):236-247
pubmed: 30847262
J Pharm Biomed Anal. 2008 Jan 22;46(2):335-41
pubmed: 18055153
Anticancer Drugs. 1997 Jun;8(5):470-81
pubmed: 9215611
J Pharm Sci. 2007 Nov;96(11):3052-71
pubmed: 17722003
Curr Pharm Des. 2013;19(11):2047-69
pubmed: 23116312
Cell. 2007 Sep 7;130(5):765-8
pubmed: 17803897
Bioorg Med Chem Lett. 2016 Dec 1;26(23):5650-5656
pubmed: 27843113
Br J Nutr. 2010 Jun;103(11):1545-57
pubmed: 20100380
Hematopathol Mol Hematol. 1997-1998;11(1):49-62
pubmed: 9439980
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
pubmed: 18156677
Eur J Med Chem. 2016 Nov 10;123:727-736
pubmed: 27521589

Auteurs

Atiruj Theppawong (A)

SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Tim Van de Walle (T)

SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Charlotte Grootaert (C)

Department of Food Technology, Safety and Health, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Kristof Van Hecke (K)

XStruct, Department of Chemistry, Faculty of Science Ghent University Krijgslaan 281, S3 B-9000 Ghent Belgium.

Nathalie Catry (N)

SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Tom Desmet (T)

Department of Biotechnology, Faculty of Bioscience Engineering Ghent University Coupure Links 653, 9000 Ghent Belgium.

John Van Camp (J)

Department of Food Technology, Safety and Health, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Matthias D'hooghe (M)

SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering Ghent University Coupure Links 653 B-9000 Ghent Belgium.

Classifications MeSH